1. Serum exosomal miR‐3662 down‐regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells
   Xiang Li et al, 2024, Chemical Biology & Drug Design CrossRef
2. Engineered extracellular vesicles for combinatorial TNBC therapy: SR-SIM-guided design achieves substantial drug dosage reduction
   Abhjeet S. Bhullar et al, 2024, Molecular Therapy CrossRef
3. Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
   Domiziana Masci et al, 2023, Molecules CrossRef
4. Non-viral Suicide Gene Therapy: Cytosine Deaminase Gene Directed by VEGF Promoter and 5-fluorocytosine as a Gene Directed Enzyme/prodrug System in Breast Cancer Model
   Manouchehr Emamian et al, 2021, Drug Research CrossRef